NewcelX NCEL
NASDAQ NCEL
$3.26 -0.11 (-3.18%)
As of: Aug 21, 2026 · 1:20 PM EDT

NewcelX (NCEL) Total Debt (2019 - 2025)

NewcelX (NCEL) posted quarterly Total Debt of $355000.0 for Q4 2025, up 21.16% year-over-year from $293000.0 in Q4 2024, and up 21.16% quarter-over-quarter from $293000.0 in Q4 2024.

NewcelX (NCEL) Total Debt (2019 - 2025) Analysis & Trends

NewcelX (NCEL) has reported Total Debt for 6 consecutive years, with $355000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Debt rose 21.16% year-over-year to $355000.0; the TTM figure through Dec 2025 stood at $355000.0 (up 21.16% YoY), while the FY2025 annual figure was $355000.0, up 21.16% from the prior year.
  • Total Debt improved to $355000.0 in Q4 2025 per NCEL's latest filing, from $293000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $355000.0 in Q4 2025 and bottomed at $292000.0 in Q4 2022.
  • Historically, Total Debt has averaged $318619.4 across 4 years, with a median of $317000.0 in 2024.
  • Annual changes were most pronounced in 2023 — Total Debt fell 10.25% — and 2025, when it climbed 21.16%.
  • NewcelX's Total Debt stood at $292000.0 in 2022, then climbed by 3.08% to $301000.0 in 2023, then retreated by 2.66% to $293000.0 in 2024, then grew by 21.16% to $355000.0 in 2025.
  • Business Quant data shows NCEL's Total Debt at $355000.0 in Q4 2025, $293000.0 in Q4 2024, and $317000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.07 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 770.36 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.34 Bn
10 NewcelX 12.54 Mn 10.34 Mn - 355,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 355,000.00
Dec 31, 2024 293,000.00
Jun 30, 2024 317,000.00
Dec 31, 2023 301,000.00
Jun 30, 2023 318,000.00
Dec 31, 2022 292,000.00
Jun 30, 2022 354,336.00
Dec 31, 2020 744,995.00
Dec 31, 2019 150,000.00